Evidence map›Paper›PMID 41924537›Full record

ArticleInternational journal of general medicine2026

Echocardiographic Risk Factors for Atrial Fibrillation Recurrence Following Radiofrequency Catheter Ablation: A Retrospective Analysis.

Huishan He, Shan Yuan, Shajin He

Abstract read
In one paragraph

Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Huishan HeDepartment of Cardiology, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, 563000, People's Republic of China.
Shan YuanDepartment of Cardiology, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, 563000, People's Republic of China.
Shajin HeDepartment of Cardiology, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, 563000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the value of pre-procedural echocardiography (ECHO) parameters for predicting recurrence following radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) and develop a predictive model. Methods: In this retrospective study of 103 AF patients undergoing first-time RFCA, pre-ablation ECHO parameters were analyzed. The primary endpoint was AF recurrence after 3-month "blanking period". Independent predictors were identified employing univariate and Firth-penalized multivariate logistic regression. Model performance was evaluated via ROC curve analysis, Bootstrap validation, calibration curves, and decision curve analysis (DCA). A predictive nomogram was generated based on the final model. Results: AF recurrence occurred in 32 patients (31.1%). Univariate analysis revealed that the recurrence group exhibited remarkably greater left atrial diameter (LAD), left atrial volume index (LAVI), mitral inflow early diastolic velocity (E-wave), E/A ratio, and E/e' ratio, while the average early diastolic mitral annular tissue velocity (e') was significantly lower (all Conclusion: Pre-procedural LAVI and E/e' ratio are independent predictors of AF recurrence post-RFCA. The combined model demonstrates promising predictive performance, warranting further external validation before clinical application.

Indexed as

atrial fibrillationechocardiographyradiofrequency catheter ablationrecurrencerisk factors

Identifiers

PMID41924537
PMCPMC13037629

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.